|1|MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor. (23135210)
Halon A.... Surowiak P.
|2|Increased incidence of severe gastrointestinal events with first-line paclitaxel, carboplatin, and vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer. (23385285)
Mendivil A.A.... Goldstein B.H.
|3|Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma. (22524817)
Suprasert P.... Manopunya M.
|4|Junctional epithelial zones of the fallopian tube: cancer hotspots? (21131841)
Rabban J.T.... Zaloudek C.J.
|5|Asymptomatic primary fallopian tube cancer: an unusual cause of axillary lymphadenopathy. (22567506)
Healy N.A.... Sweeney K.J.
|6|Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer. (21664657)
Landrum L.M.... Walker J.L.
|7|Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer. (21324515)
Holmberg L.A.... Veljovich D.
|8|Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. (19901115)
Makhija S.... Matulonis U.
|9|Immunohistochemical findings in primary fallopian tube cancer. Case report. (20349798)
Raba G.... Kanczuga-Koda L.
|10|Cancer-associated retinopathy in neuroendocrine carcinoma of the fallopian tube. (20724944)
Raghunath A.... Schiffman J.S.
|11|A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer. (19264351)
Schmeler K.M.... Freedman R.S.
|12|Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer. (19224848)
Teneriello M.G.... Asmar L.
|13|High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy. (19574767)
Hirst J.E.... Field M.
|14|Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. (19091388)
Kehoe S.M.... Chi D.S.
|15|Case report: Occurrence of fallopian tube cancer in a patient with previous history of estrogen receptor positive breast cancer. (20103847)
Chung C.... Yen Y.
|16|Systematic lymphadenectomy improves survival in patients with advanced-stage primary fallopian tube cancer. (19398867)
Kim Y.M.... Nam J.H.
|17|Liquid-based cytology aids in primary fallopian tube cancer diagnosis. (19650204)
Ren Z.... Zhu L.R.
|18|Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database. (19308749)
Petri A.L.... Hogdall C.
|19|A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer. (18554700)
Konner J.... Aghajanian C.A.
|20|A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. (18342932)
Folkins A.K.... Crum C.P.
|21|Fallopian tube cancer associated with paraneoplastic dermatomyositis -- asymptomatic multivisceral exacerbated dermatomyositis mimicking recurrent widespread malignant disease: case report. (18459555)
Seeber J.... Zeimet A.G.
|22|Synchronous occult cancers of the endometrium and fallopian tube in an MSH2 mutation carrier at time of prophylactic surgery. (18805575)
Palma L.... Foulkes W.D.
|23|Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group. (18597837)
Morgan M.A.... Egorin M.J.
|24|Fallopian tube cancer: radical surgery, extended field radiation and chemotherapy in 24 personal cases treated with "intent to cure". (18973932)
|25|Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. (19006196)
Wethington S.L.... Wright J.D.
|26|Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium. (18538834)
Goff B.A.... Kurland B.F.
|27|Occult fallopian tube cancer in a patient with BRCA1 breast cancer. (18971141)
Brown J.V.... Goldstein B.H.
|28|Primary fallopian tube cancer may mimic endometrial malignancy. (18603511)
Lin C.K.... Yu M.H.
|29|Second primary malignancies in females with primary fallopian tube cancer. (17266029)
Riska A.... Brennan P.
|30|A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer. (17343605)
Micha J.P.... Brown J.V.
|31|Fallopian tube cancer: stepchild or mother? (18053873)
|32|Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. (17761984)
Callahan M.J.... Muto M.G.
|33|Phenotypic variability of a 4q34-->qter inherited deletion: MRKH syndrome in the daughter, cardiac defect and Fallopian tube cancer in the mother. (17081814)
Bendavid C.... Guerrier D.
|34|A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers. (16445606)
Benoit M.F.... Hannigan E.V.
|35|Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. (16835424)
Finch A.... Narod S.A.
|36|Inguinal node metastasis as the initial presentation of primary fallopian tube cancer. (16876236)
Cho J.... DA-az-Montes T.P.
|37|The significance of Doppler flow and anamnesis in the diagnosis of fallopian tube cancer. (15991534)
Gojnic M.... Jeremic K.
|38|A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. (15581974)
Berkenblit A.... Cannistra S.A.
|39|Occult cancer of the fallopian tube in a BRCA2 germline mutation carrier at prophylactic salpingo-oophorectomy. (14984974)
McEwen A.R.... Kidd A.M.
|40|Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneum. (15331919)
Markman M.... Lindner D.
|41|Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum. (14675679)
Markman M.... Belinson J.
|42|Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer. (12354934)
Jongsma A.P.... Kenemans P.
|43|Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass. (11205221)
Scholz H.S.... Petru E.
|44|Fallopian tube cancer as a feature of BRCA1-associated syndromes. (10926816)
Sobol H.... Eisinger F.
|45|Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. (10620440)
Zweemer R.P.... Kenemans P.
|46|Prognostic significance of tumor angiogenesis in primary fallopian tube cancer. (10454260)
Bancher-Todesca D.... Obermair A.
|47|Fallopian tube cancer: incidence and role of lymphatic spread. (8751549)
di Re E.... Baiocchi G.
|48|Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study. (9816118)
Chambers S.K.... Chambers J.T.
|49|Fallopian tube cancer. The Roswell Park experience. (2249208)
Rose P.G.... Tsukada Y.
|50|Fallopian tube cancer: the role of radiation therapy. (3444903)
Schray M.F.... Malkasian G.D.